QUELICIN (succinylcholine chloride) Injection, USP, 200 mg (20 mg/mL) 10 mL, Rx only, HOSPIRA, INC. LAKE FOREST, IL 60045 USA, , NDC 0409-6629-02
Published May 15, 2013 · Recall initiated: February 26, 2013
Summary
FDA records drug Class II recall D-315-2013, published May 15, 2013 and initiated February 26, 2013. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 139,200 vials; Lot: Lot 21-480-EV Exp.12/13. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial.
What to do
Voluntary: Firm initiated · Letter
Get an email if QUELICIN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- QUELICIN
- Manufacturer
- Hospira Inc.
- Distributor
- Nationwide and Puerto Rico
- Lot
- Lot 21-480-EV Exp.12/13
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASuccinylcholine Chloride Injection, USP 200 mg (20 mg/mL) Quelicin Multiple-dose vial, 10 mL, For I.V. or I.M.August 9, 2017
- FDAFurosemide Injection, USP, 40 mg/4mL (10 mg/mL), 4 ml Single-Dose Vial, Rx only, HOSPIRA, INC. LAKE FOREST, ILMay 15, 2013
- FDASodium Acetate Injection, USP, 40 mEq/20 ml (2 mEq/mL) 20 mL Single-Dose Fliptop, Rx only, HOSPIRA, INC. LAKEMay 15, 2013
- FDADiazepam Injection, USP 5 mg/mL, 10 mL, Multiple-dose fliptop vial, RX only, HOSPIRA, INC. LAKE FOREST, ILMay 15, 2013
- FDAPlavix 75 mg, 30 count bottle, NDC (54868-4070-0), Rx only, Manufactured by Bristol-Meyers Squibb,May 15, 2013
- FDANxStage PureFlow-B Solution, Model/Catalog Number: RFP-401, packaged in a case The NxStage PureFLow-B SolutionMay 8, 2013
Questions about this recall
Was QUELICIN (succinylcholine chloride) Injection, USP, 200 mg (20 mg/mL) 10 mL, Rx only, HOSPIRA, INC. LAKE FOREST, IL 60045 USA, , NDC 0409-6629-02 recalled?
Yes. FDA published recall D-315-2013 on May 15, 2013. Reported hazard: Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: QUELICIN.